Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer

Clinical Nutrition

Volumn 31, Issue 1, 2012, Pages 74-77

  Awad, Sherif ^a   Tan, Benjamin H ^a   Cui, Helen ^a   Bhalla, Ashish ^a   Fearon, Kenneth C H ^b   Parsons, Simon L ^c   Catton, James A ^c   Lobo, Dileep N ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Body composition; Cancer; Chemotherapy; Gastric; Oesophageal; Outcomes; Sarcopenia; Surgery

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; BODY COMPOSITION; BODY FAT; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; LENGTH OF STAY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE ATROPHY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; PARTIAL GASTRECTOMY; PNEUMONIA; POSTOPERATIVE COMPLICATION; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA;

AGED; BODY COMPOSITION; FEMALE; GASTROINTESTINAL NEOPLASMS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OBESITY; PILOT PROJECTS; POSTOPERATIVE CARE; PREVALENCE; SARCOPENIA; TREATMENT OUTCOME;

EID: 84856216341     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.08.008     Document Type: Article

References (15)

1. Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
2. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. JAm Geriatr Soc 2002, 50:889-896.
3. Pichard C., Kyle U.G., Morabia A., Perrier A., Vermeulen B., Unger P. Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 2004, 79:613-618.
4. Cosqueric G., Sebag A., Ducolombier C., Thomas C., Piette F., Weill-Engerer S. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 2006, 96:895-901.
5. Metter E.J., Talbot L.A., Schrager M., Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. JGerontol A Biol Sci Med Sci 2002, 57:B359-B365.
6. Tan B.H., Birdsell L.A., Martin L., Baracos V.E., Fearon K.C. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009, 15:6973-6979.
7. Awad S., Lobo D.N. What's new in perioperative nutritional support?. Curr Opin Anaesthesiol 2011, 24:339-348.
8. Bower M.R., Martin R.C. Nutritional management during neoadjuvant therapy for esophageal cancer. JSurg Oncol 2009, 100:82-87.
9. Prado C.M., Baracos V.E., McCargar L.J., Reiman T., Mourtzakis M., Tonkin K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009, 15:2920-2926.
10. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629-635.
11. Windsor J.A., Hill G.L. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann Surg 1988, 207:290-296.
12. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. NEngl J Med 2006, 355:11-20.
13. Pichard C., Baracos V., Attaix D. Would you buy a new tool to improve your practice?. Curr Opin Clin Nutr Metab Care 2011, 14:221-222.
14. Baracos V.E., Reiman T., Mourtzakis M., Gioulbasanis I., Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010, 91:1133S-1137S.
15. Ryan A.M., Reynolds J.V., Healy L., Byrne M., Moore J., Brannelly N., et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2009, 249:355-363.